Viewing Study NCT00075634


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-26 @ 12:54 AM
Study NCT ID: NCT00075634
Status: COMPLETED
Last Update Posted: 2013-09-30
First Post: 2004-01-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module